Cardiovascular disease is the number one cause of death globally and it’s on the rise. At the same time the patient population is growing, it’s also becoming more complex. More people are suffering from a range of confounding comorbidities that necessitate more personalized treatments. Combined with changing regulations and fewer resources, health systems face a significant challenge to provide high-level individualized care to complex heart disease patients without incurring incremental risks or costs.